Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic versus intratympanic corticosteroids for sudden sensorineural hearing loss with balance disorders
IRCT20230721058871N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute sensorineural hearing loss comparing Intratympanic methylprednisolone with Systemic prednisolone (2 arms). Primary endpoint: vestibular function. Started Aug 2023; status: completed.
02
Drugs
prednisolonemethylprednisolone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT20230721058871N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230721058871N1.